Home | About the Medical Center | Donate or Volunteer | Contact Us
Home > Clinical Trials >
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of an Experimental Anti-Fungal versus an FDA-Approved Anti-Fungal for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi
A Prospective, Randomized Trial Comparing the Efficacy of an Experimental (Not Approved by the FDA) Anti-Fungal and an FDA-Approved Anti-Fungal in Combination to that of the FDA-Approved Anti-Fungal Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis
Notice of Privacy Practices | Legal Disclaimer | Contact Us | Site Map
Call HealthLink toll-free at 1-888-UCH-0200. Copyright © 2009 University of Chicago Medical Center. All rights reserved.
E-mail page